Abstract:By incorporating the large‐sized Si atom, the A‐D‐A type photosensitizer SiO‐4F demonstrates an enhanced photothermal conversion efficiency of 64.23%. The water‐soluble nanoparticle prepared based on SiO‐4F exhibits an effective inhibition of tumor growth and complete elimination of tumor, enabling photothermal therapy under NIR irradiation that meets medical safety standards. Due to the inadequate photothermal conversion efficiency (PCE), most photothermal agents (PTAs) have to be used under high‐power near‐infrared (NIR) irradiation, which significantly exceeds medical safety standards, for achieving effective photothermal therapy (PTT) in antitumor treatment. This significantly hinders practical PTT application. Herein, three acceptor‐donor‐acceptor(A‐D‐A)‐type molecules are synthesized based on cyclopentadithiophene unit to develop effective PTAs. By incorporating the large‐size Si atom in the A‐D‐A molecules, the photosensitizer displays an increased packing distance in the aggregate state, leading to a blue‐shifted absorption spectrum that better matches the medial laser wavelength. Also, the Si incorporation strategy elevates the nonradiative decay rate constants (knr) of the A‐D‐A photosensitizer, and thereby a further enhancement in PCE is achieved for the PTA. Consequently, the SiO‐4F‐based nanoparticles exhibited 64.23% PCE, with excellent biosafety and photothermal stability. Under NIR irradiation with medical safety (808 nm, 0.33 W cm−2), SiO‐4F nanoparticles with 100 μg mL−1 yield a death rate of over 91% for diverse tumor cells. Moreover, in vivo experiments, SiO‐4F‐based PTT effectively inhibited and eliminated tumors. These findings suggest that the Si‐incorporated CDPT is promising for constructing effective A‐D‐A photosensitizers, enabling the PTT under NIR irradiation that meets medical safety standards.

Acceptor-donor-acceptor-type Molecules with large electrostatic potential difference for Effective NIR Photothermal Theranostics

Acceptor-donor-acceptor-type Molecules with Large Electrostatic Potential Difference for Effective NIR Photothermal Therapy

Near-Infrared Conjugated Polymers Containing Thermally Activated Delayed Fluorescence Units Enable Enhanced Photothermal Therapy

Acceptor-donor-acceptor type organic photothermal agents with enhanced NIR absorption and photothermal conversion effect for cancer photothermal therapy

Novel BODIPY-based Nano-Biomaterials with Enhanced D-A-D Structure for NIR-triggered Photodynamic and Photothermal Therapy

Nir‐Ii Emissive Superoxide Radical Photogenerator for Photothermal/photodynamic Therapy Against Hypoxic Tumor

Stable Alkyne‐Bridged Conjugated Polymer Nanoparticles With a High NIR‐II Photothermal Conversion Efficiency of 71% for Effective Photothermal Tumor Therapy

Novel Dibenzofulvene‐Based NIR‐II Emission Phototheranostic Agent with an 82.6% Photothermal Conversion Efficiency for Photothermal Therapy

Synchronously Manipulating the D−A Interaction and Planarity in Semiconducting Polymers to Achieve 84.7% Photothermal Conversion Efficiency for NIR‐II Imaging‐Guided Tumor Therapy

Aggregation-Induced Emission-Active Organic Nanoagent with High Photothermal Conversion Efficiency for Near-Infrared Imaging-Guided Tumor Photothermal Therapy

Biocompatible Conjugated Polymer Nanoparticles for Efficient Photothermal Tumor Therapy

880 nm NIR-Triggered Organic Small Molecular-Based Nanoparticles for Photothermal Therapy of Tumor

Small‐Molecule Phototheranostic Agent with Extended π‐Conjugation for Efficient NIR‐II Photoacoustic‐Imaging‐Guided Photothermal Therapy

A-DA′D-A Structured Organic Phototheranostics for NIR-II Fluorescence/Photoacoustic Imaging-Guided Photothermal and Photodynamic Synergistic Therapy

Enhanced Photothermal Therapy under Low‐Power Near‐Infrared Irradiation Enabled by a Si‐Cyclopentadithiophene‐Based Organic Molecule

A-DA'D-A Structured Organic Phototheranostics for NIR-II Fluorescence/Photoacoustic Imaging-Guided Photothermal and Photodynamic Synergistic Therapy.

Quinoid Conjugated Polymer Nanoparticles with NIR-II Absorption Peak Toward Efficient Photothermal Therapy**

BF2‐Bridged Azafulvene Dimer‐Based 1064 nm Laser‐Driven Superior Photothermal Agent for Deep‐Seated Tumor Therapy

High‐Performance NIR‐II Fluorescent Type I/II Photosensitizer Enabling Augmented Mild Photothermal Therapy of Tumors by Disrupting Heat Shock Proteins

Development of novel nanoporphyrin biomaterials for NIR-II activated photothermal therapy against tumor in vivo

Dual-Peak Absorbing Semiconducting Copolymer Nanoparticles for First and Second Near-Infrared Window Photothermal Therapy: A Comparative Study.